Literature DB >> 1138738

Malignant hypertension associated with use of oral contraceptives.

F G Dunn, J V Jones, R Fife.   

Abstract

A 26-year-old woman who had been taking an oral contraceptive preparation for two years developed malignant hypertension. Investigation failed to elicit any renal or other cause for her hypertension, but control of blood pressure was obtained by withdrawal of the oral contraceptive agent and antihypertensive therapy. Subsequently, after withdrawal of therapy, the blood pressure remained near normal. The patient had a previous history of hypertension during pregnancy; she was also overweight.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138738      PMCID: PMC483976          DOI: 10.1136/hrt.37.3.336

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  Irreversible renal failure secondary to hypertension induced by oral contraceptives.

Authors:  B J Zacherle; J A Richardson
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

2.  Blood-pressure in women after one year of oral contraception.

Authors:  E Briggs; A Mack; L Taylor; J Browning; L Naismith; E Wilson; R J Weir
Journal:  Lancet       Date:  1971-03-06       Impact factor: 79.321

3.  Angiotensin II blood-levels in human hypertension.

Authors:  K J Catt; E Cran; P Z Zimmet; J B Best; M D Cain; J P Coghlan
Journal:  Lancet       Date:  1971-03-06       Impact factor: 79.321

4.  Malignant hypertension associated with oral contraceptives.

Authors:  P W Harris
Journal:  Lancet       Date:  1969-08-30       Impact factor: 79.321

5.  Blood pressure in women taking oral contraceptives.

Authors:  R J Weir; E Briggs; A Mack; L Naismith; L Taylor; E Wilson
Journal:  Br Med J       Date:  1974-03-23

6.  Oral contraceptives and hypertension. An epidemiological survey.

Authors:  T M Clezy; B N Foy; R L Hodge; E R Lumbers
Journal:  Br Heart J       Date:  1972-12

7.  Effects of oestrogens on the human circulation.

Authors:  Y L Lim; E R Lumbers; W A Walters; R F Whelan
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-04

8.  Oral contraceptives and hypertension.

Authors:  J W Woods
Journal:  Lancet       Date:  1967-09-23       Impact factor: 79.321

9.  Oral contraceptives. Renin, aldosterone, and high blood pressure.

Authors:  J H Laragh; J E Sealey; J G Ledingham; M A Newton
Journal:  JAMA       Date:  1967-09-18       Impact factor: 56.272

  9 in total
  10 in total

Review 1.  Drug-induced hypertension: pathogenesis and management.

Authors:  G S Stokes
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon.

Authors:  C M Doolan; S B Condliffe; B J Harvey
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

4.  Hypertension and oral contraceptives.

Authors: 
Journal:  Br Med J       Date:  1978-06-17

5.  Encephalopathy in renovascular hypertension associated with the use of oral contraceptives.

Authors:  J R Bradley; J Reynolds; P F Williams; D S Appleton
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

6.  Malignant hypertension in women of childbearing age and its relation to the contraceptive pill.

Authors:  K G Lim; C G Isles; G P Hodsman; A F Lever; J W Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

Review 7.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04

Review 8.  Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities.

Authors:  Madugodaralalage D S K Gunaratne; Bjorg Thorsteinsdottir; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2021-05-13       Impact factor: 5.369

9.  Past oral contraceptive use and self-reported high blood pressure in postmenopausal women.

Authors:  Christine L Chiu; Joanne M Lind
Journal:  BMC Public Health       Date:  2015-01-31       Impact factor: 3.295

10.  Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature.

Authors:  Danial Mir; Arash Ardabilygazir; Sonia Afshariyamchlou; Issac Sachmechi
Journal:  Cureus       Date:  2018-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.